Finance

Lists
Why is MAP down 2,50%?
Dive Deeper
MAP:ASX
Microba Life Sciences Ltd
A$0,039
-2,50%
(-0,00100) 1D
22 āš•.āšĨ., 15 āŧ‚āšĄāš‡ 57 āš™āšēāš—āšĩ 21 āš§āšīāš™āšēāš—āšĩ GMT+11  ·   AUD
All symbols
SymbolPriceChange% Change
Generating top insights for MAP...
Open
A$0,04
High
A$0,04
Low
A$0,03
Mkt. cap
30,76 āšĨāŧ‰āšēāš™
Avg. vol.
452,26Â āšžāšąāš™
Volume
1,34 āšĨāŧ‰āšēāš™
52-wk high
A$0,10
52-wk low
A$0,03
EPS
A$-0,03
Shares outstanding
717,12 āšĨāŧ‰āšēāš™
Open
A$0,04
High
A$0,04
Low
A$0,03
Mkt. cap
30,76 āšĨāŧ‰āšēāš™
Avg. vol.
452,26Â āšžāšąāš™
Volume
1,34 āšĨāŧ‰āšēāš™
52-wk high
A$0,10
52-wk low
A$0,03
EPS
A$-0,03
Shares outstanding
717,12 āšĨāŧ‰āšēāš™
News stories
From web sources and news partners
Kalkine
Kalkine
·
1 āšŠāšŧāŧˆāš§āŧ‚āšĄāš‡āšāŧˆāš­āš™
How Are Microba Life Sciences (ASX:MAP) Shares Faring After a 10% Drop?
About Microba Life Sciences Ltd
CEO-
Employees-
Founded2017
Headquarters-
SectorHealth care provider
Last report
16 āš.āšĨ. 2026
Fiscal period
Q4 2026
- / -
Revenue / Est. (AUD)
3,72 āšĨāŧ‰āšēāš™ / -
Fiscal Q4 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in AUD
Loading Previous Earnings...
Revenue
Net income
All values in AUD
āš.āš. 2025
āš—.āš§. 2025
āšĄ.āš™. 2026
āšĄāšī.āš–. 2026
Revenue
3,66 āšĨāŧ‰āšēāš™
3,66 āšĨāŧ‰āšēāš™
3,72 āšĨāŧ‰āšēāš™
3,72 āšĨāŧ‰āšēāš™
Cost of goods sold
1,98 āšĨāŧ‰āšēāš™
1,98 āšĨāŧ‰āšēāš™
1,88 āšĨāŧ‰āšēāš™
1,88 āšĨāŧ‰āšēāš™
Cost of revenue
1,98 āšĨāŧ‰āšēāš™
1,98 āšĨāŧ‰āšēāš™
1,88 āšĨāŧ‰āšēāš™
1,88 āšĨāŧ‰āšēāš™
Research and development expenses
142,04Â āšžāšąāš™
142,04Â āšžāšąāš™
66,49Â āšžāšąāš™
66,49Â āšžāšąāš™
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
5,06 āšĨāŧ‰āšēāš™
5,06 āšĨāŧ‰āšēāš™
4,71 āšĨāŧ‰āšēāš™
4,71 āšĨāŧ‰āšēāš™
Operating expense
7,13 āšĨāŧ‰āšēāš™
7,13 āšĨāŧ‰āšēāš™
6,54 āšĨāŧ‰āšēāš™
6,54 āšĨāŧ‰āšēāš™
Total operating expenses
9,11 āšĨāŧ‰āšēāš™
9,11 āšĨāŧ‰āšēāš™
8,42 āšĨāŧ‰āšēāš™
8,42 āšĨāŧ‰āšēāš™
Operating income
-5,45 āšĨāŧ‰āšēāš™
-5,45 āšĨāŧ‰āšēāš™
-4,70 āšĨāŧ‰āšēāš™
-4,70 āšĨāŧ‰āšēāš™
Other non operating income
658,46Â āšžāšąāš™
658,46Â āšžāšąāš™
115,51Â āšžāšąāš™
115,51Â āšžāšąāš™
EBT including unusual items
-5,40 āšĨāŧ‰āšēāš™
-5,40 āšĨāŧ‰āšēāš™
-5,09 āšĨāŧ‰āšēāš™
-5,09 āšĨāŧ‰āšēāš™
EBT excluding unusual items
-5,03 āšĨāŧ‰āšēāš™
-5,03 āšĨāŧ‰āšēāš™
-5,06 āšĨāŧ‰āšēāš™
-5,06 āšĨāŧ‰āšēāš™
Income tax expense
-125,26Â āšžāšąāš™
-125,26Â āšžāšąāš™
-6,04Â āšžāšąāš™
-6,04Â āšžāšąāš™
Effective tax rate
2,32%
2,32%
0,12%
0,12%
Other operating expenses
828,78Â āšžāšąāš™
828,78Â āšžāšąāš™
652,54Â āšžāšąāš™
652,54Â āšžāšąāš™
Net income
-5,28 āšĨāŧ‰āšēāš™
-5,28 āšĨāŧ‰āšēāš™
-5,08 āšĨāŧ‰āšēāš™
-5,08 āšĨāŧ‰āšēāš™
Net profit margin
-144,21%
-144,21%
-136,65%
-136,65%
Earnings per share
-
-
-
-
Interest and investment income
105,25Â āšžāšąāš™
105,25Â āšžāšąāš™
52,55Â āšžāšąāš™
52,55Â āšžāšąāš™
Interest expense
-44,59Â āšžāšąāš™
-44,59Â āšžāšąāš™
-74,69Â āšžāšąāš™
-74,69Â āšžāšąāš™
Net interest expenses
60,66Â āšžāšąāš™
60,66Â āšžāšąāš™
-22,14Â āšžāšąāš™
-22,14Â āšžāšąāš™
Depreciation and amortization charges
1,10 āšĨāŧ‰āšēāš™
1,10 āšĨāŧ‰āšēāš™
1,10 āšĨāŧ‰āšēāš™
1,10 āšĨāŧ‰āšēāš™
EBITDA
-4,70 āšĨāŧ‰āšēāš™
-4,70 āšĨāŧ‰āšēāš™
-4,62 āšĨāŧ‰āšēāš™
-4,62 āšĨāŧ‰āšēāš™
Gain or loss from assets sale
-
-
48,64Â āšžāšąāš™
48,64Â āšžāšąāš™
AI content may include mistakes. Learn more
āŧāš­āšąāššāš‚āš­āš‡ Google